Résultats de la recherche - Witjes, Han
- Résultat(s) 1 - 10 résultats de 10
-
1
-
2
Meta‐Analyses of Clinical Efficacy of Risankizumab and Adalimumab in Chronic Plaque Psoriasis: Supporting Evidence of Risankizumab Superiority par Witjes, Han, Khatri, Amit, Diderichsen, Paul M., Mandema, Jaap, Othman, Ahmed A.
Publié 2019Texte -
3
Clinical impact of LH rises prior to and during ganirelix treatment started on day 5 or on day 6 of ovarian stimulation par Frattarelli, John L, Hillensjö, Torbjörn, Broekmans, Frank J, Witjes, Han, Elbers, Jolanda, Gordon, Keith, Mannaerts, Bernadette
Publié 2013Texte -
4
Population pharmacokinetics and exposure‐response of osimertinib in patients with non‐small cell lung cancer par Brown, Kathryn, Comisar, Craig, Witjes, Han, Maringwa, John, de Greef, Rik, Vishwanathan, Karthick, Cantarini, Mireille, Cox, Eugène
Publié 2017Texte -
5
Prognostic models for high and low ovarian responses in controlled ovarian stimulation using a GnRH antagonist protocol par Broekmans, Frank J., Verweij, Pierre J.M., Eijkemans, Marinus J.C., Mannaerts, Bernadette M.J.L., Witjes, Han
Publié 2014Texte -
6
Maternal–Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing par Lommerse, Jos, Clarke, Diana, Kerbusch, Thomas, Merdjan, Henri, Witjes, Han, Teppler, Hedy, Mirochnick, Mark, Acosta, Edward P., Wenning, Larissa, Nachman, Sharon, Chain, Anne
Publié 2019Texte -
7
Population Pharmacokinetic Modeling to Evaluate Standard Magnesium Sulfate Treatments and Alternative Dosing Regimens for Women With Preeclampsia par Du, Lihong, Wenning, Larissa, Migoya, Elizabeth, Xu, Yan, Carvalho, Brendan, Brookfield, Kathleen, Witjes, Han, de Greef, Rik, Lumbiganon, Pisake, Sangkomkamhang, Ussanee, Titapant, Vitaya, Duley, Lelia, Long, Qian, Oladapo, Olufemi T.
Publié 2018Texte -
8
Alternative Magnesium Sulfate Dosing Regimens for Women With Preeclampsia: A Population Pharmacokinetic Exposure‐Response Modeling and Simulation Study par Du, Lihong, Wenning, Larissa A., Carvalho, Brendan, Duley, Lelia, Brookfield, Kathleen F., Witjes, Han, de Greef, Rik, Lumbiganon, Pisake, Titapant, Vitaya, Kongwattanakul, Kiattisak, Long, Qian, Sangkomkamhang, Ussanee S., Gülmezoglu, Ahmet M., Oladapo, Olufemi T.
Publié 2019Texte -
9
998. Forward and Reverse Translational Approaches to Predict Efficacy of the Neutralizing Respiratory Syncytial Virus (RSV) Antibody MK-1654 par Maas, Brian M, Lommerse, Jos, Plock, Nele, Railkar, Radha, Amy Cheung, S Y, Caro, Luzelena, Chen, Jingxian, Liu, Wen, Zhang, Ying, Huang, Qinlei, Gao, Wei, Qin, Li, Meng, Jie, Witjes, Han, Schindler, Emilie, Guiastrennec, Benjamin, Bellanti, Francesco, Spellman, Daniel, Roadcap, Brad, Kalinova, Mariya, Fok-Seang, Juin, Catchpole, Andrew P, Espeseth, Amy, Aubrey Stoch, S, Lai, Eseng, Vora, Kalpit A, Aliprantis, Antonios O, Sachs, Jeffrey R
Publié 2021Texte -
10
Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxis par Maas, Brian M., Lommerse, Jos, Plock, Nele, Railkar, Radha A., Cheung, S.Y. Amy, Caro, Luzelena, Chen, Jingxian, Liu, Wen, Zhang, Ying, Huang, Qinlei, Gao, Wei, Qin, Li, Meng, Jie, Witjes, Han, Schindler, Emilie, Guiastrennec, Benjamin, Bellanti, Francesco, Spellman, Daniel S., Roadcap, Brad, Kalinova, Mariya, Fok-Seang, Juin, Catchpole, Andrew P., Espeseth, Amy S., Stoch, S. Aubrey, Lai, Eseng, Vora, Kalpit A., Aliprantis, Antonios O., Sachs, Jeffrey R.
Publié 2021Texte